Sunday 25 September 2011

Mirtazapin Orion




Mirtazapin Orion may be available in the countries listed below.


Ingredient matches for Mirtazapin Orion



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapin Orion in the following countries:


  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Hungary

  • Slovakia

  • Sweden

International Drug Name Search

Saturday 24 September 2011

Glucodex




Glucodex may be available in the countries listed below.


Ingredient matches for Glucodex



Gliclazide

Gliclazide is reported as an ingredient of Glucodex in the following countries:


  • Indonesia

International Drug Name Search

Friday 16 September 2011

Preventic-B




Preventic-B may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Preventic-B



Bendiocarb

Bendiocarb is reported as an ingredient of Preventic-B in the following countries:


  • Netherlands

International Drug Name Search

Thursday 15 September 2011

Pasta Devitalizzante




Pasta Devitalizzante may be available in the countries listed below.


Ingredient matches for Pasta Devitalizzante



Formaldehyde

Formaldehyde is reported as an ingredient of Pasta Devitalizzante in the following countries:


  • Italy

Lidocaine

Lidocaine is reported as an ingredient of Pasta Devitalizzante in the following countries:


  • Italy

International Drug Name Search

Wednesday 14 September 2011

Nucidol




Nucidol may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Nucidol



Dimpylate

Dimpylate is reported as an ingredient of Nucidol in the following countries:


  • Ireland

International Drug Name Search

Lacryvisc




Lacryvisc may be available in the countries listed below.


Ingredient matches for Lacryvisc



Carbomer

Carbomer is reported as an ingredient of Lacryvisc in the following countries:


  • Chile

  • France

  • Hong Kong

  • Mexico

  • Portugal

  • Singapore

  • Slovenia

  • Spain

  • Switzerland

  • Tunisia

  • Turkey

International Drug Name Search

Monday 12 September 2011

Lapicef




Lapicef may be available in the countries listed below.


Ingredient matches for Lapicef



Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Lapicef in the following countries:


  • Indonesia

International Drug Name Search

Saturday 10 September 2011

Unidox Solutab




Unidox Solutab may be available in the countries listed below.


Ingredient matches for Unidox Solutab



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Unidox Solutab in the following countries:


  • Georgia

  • Russian Federation

International Drug Name Search

Thursday 8 September 2011

Qutenza


Qutenza is a brand name of capsaicin topical, approved by the FDA in the following formulation(s):


QUTENZA (capsaicin - patch; topical)



  • Manufacturer: NEUROGESX

    Approval date: November 16, 2009

    Strength(s): 8% [RLD]

Has a generic version of Qutenza been approved?


No. There is currently no therapeutically equivalent version of Qutenza available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Qutenza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Transdermal therapeutic device and method with capsaicin and capsaicin analogs
    Patent 6,239,180
    Issued: May 29, 2001
    Inventor(s): Robbins; Wendye R.
    Assignee(s): The Regents of the University of California
    Transdermal application of capsaicin (or a capsaicin analog) in a concentration from greater than about 5% to about 10% by weight has been discovered to be an extremely effective therapy for treating neuropathic pain, so long as an anesthetic, preferably by means of a transdermal patch, is administered initially to the affected area to minimize the expected side effects from subsequent capsaicin application.
    Patent expiration dates:

    • November 6, 2016
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • November 16, 2014 - NEW CHEMICAL ENTITY

    • November 16, 2016 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Qutenza Consumer Information (Drugs.com)
  • Qutenza Patch Consumer Information (Wolters Kluwer)
  • Qutenza Consumer Information (Cerner Multum)
  • Capsaicin Cream Consumer Information (Wolters Kluwer)
  • Capsaicin Liquid Consumer Information (Wolters Kluwer)
  • Capsaicin Lotion Consumer Information (Wolters Kluwer)
  • Capsaicin Patch Consumer Information (Wolters Kluwer)
  • Capsaicin in Lidocaine Cream Consumer Information (Wolters Kluwer)
  • Capsaicin/Menthol Patch Consumer Information (Wolters Kluwer)
  • Capsaicin topical Consumer Information (Cerner Multum)
  • Arthricare For Women Topical Advanced Consumer Information (Micromedex)
  • Capsagel Topical Advanced Consumer Information (Micromedex)
  • Capsagesic-HP Arthritis Relief Topical Advanced Consumer Information (Micromedex)
  • Capsaicin Hp Topical Advanced Consumer Information (Micromedex)
  • Double Cap Topical Advanced Consumer Information (Micromedex)
  • Icy Hot Arthritis Therapy Topical Advanced Consumer Information (Micromedex)
  • Pain Enz Topical Advanced Consumer Information (Micromedex)
  • Rid-A-Pain Topical Advanced Consumer Information (Micromedex)
  • Sportsmed Topical Advanced Consumer Information (Micromedex)
  • Therapatch Warm Topical Advanced Consumer Information (Micromedex)
  • Capsaicin Topical Advanced Consumer Information (Micromedex)

Wednesday 7 September 2011

Hexidine E




Hexidine E may be available in the countries listed below.


Ingredient matches for Hexidine E



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hexidine E in the following countries:


  • Japan

International Drug Name Search

Saturday 3 September 2011

Ketomax




Ketomax may be available in the countries listed below.


Ingredient matches for Ketomax



Ketorolac

Ketorolac is reported as an ingredient of Ketomax in the following countries:


  • Peru

International Drug Name Search

Friday 2 September 2011

Laxadyl




Laxadyl may be available in the countries listed below.


Ingredient matches for Laxadyl



Bisacodyl

Bisacodyl is reported as an ingredient of Laxadyl in the following countries:


  • Bahrain

  • Iraq

  • Kuwait

  • Lebanon

  • Libya

  • Nigeria

  • Oman

  • Qatar

  • Saudi Arabia

  • Sudan

  • Syria

  • United Arab Emirates

  • Yemen

International Drug Name Search

Thursday 1 September 2011

Blocar




Blocar may be available in the countries listed below.


Ingredient matches for Blocar



Carvedilol

Carvedilol is reported as an ingredient of Blocar in the following countries:


  • Chile

International Drug Name Search